Mohammad Keykhaei, MD, MPH

1/🚨Excited to share our new study in
@JACCJournals #JACCHeartFailure

“National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction”

shorturl.at/tnQZD

My sincere gratitude goes to Dr. @gcfmd for his exceptional mentorship and guidance, and to our outstanding team for their collaboration and support: @ATSandhu @HsuePriscilla @SJGreene_md @boback @MKIttlesonMD @MattRamsisMD @uclaimchiefs @DOM_UCLA @uclaCVfellows @UCLAHealth @UCLAHealthNews #HFrEF #GDMT

🫀 How much heart failure science can you fit into one weekend? From HFpEF to cardiomyopathy, here’s a quick guide to selected #AHA26 talks and panels. @gcfmd, @ATSandhu, @SJGreene_md, @PilarAlcaidePhD, @AHAScience, @AHAMeetings

🫀 What’s on your cardio-oncology agenda at #AHA26? From ICI myocarditis debates to the latest in cardiac amyloidosis, there’s plenty to catch.
📍See the schedule below for cardio-oncology and cardiac amyloidosis talks, panels, and moderated poster sessions. @datsunian @CardioOncology @TomasNeilan @Ron_Witteles @AHAScience @AHAMeetings #CardioOncology

💙💛 Grateful to be part of a program that values research alongside clinical excellence. UCLA Internal Medicine & Cardiology will be well represented at #AHA26 with 19 presentations. If you’re in Chicago, come support our presenters! 🫀@datsunian @A_SteinMerlob @IntMedAbel @LizGhandakly @psrajendran87 @ZiadHindosh @dgsomucla @DOM_UCLA @UCLAHealth @uclaCVfellows @uclaimchiefs @UCLA #BruinHeart #UCLAHealth
Go Bruins! 🐻

Join us at #AHA26 in Chicago! 🫀

"Defining the Cardiovascular Toxicity Landscape of Tumor-Infiltrating Lymphocyte Therapy: A Real-World Cardio-Oncology Characterization"

📌 Cardio-Oncology at the Cutting Edge: Immunotherapy-Associated Cardiotoxicity

🕒 Mon, Nov 9 · 11:48 AM CT
📍 Moderated Digital Poster 13, Clinical Science Zone 2
🖥️ MDP2328

Grateful to our co-authors and mentors @A_SteinMerlob @datsunian @qicong_sheng @DOM_UCLA @UCLAHealth @uclaCVfellows @uclaimchiefs #CardioOnc